Review of 2022 PSOGI/RENAPE Consensus on HIPEC.
Shigeki KusamuraAditi BhattKurt van Der SpeetenVahan KepenekianMartin HübnerClarisse EvenoIgnace de HinghJean-Baptiste DelhormeAbdelkader TaibiLaurent VilleneuveRea Lo DicoBrendan MoranKim GovaertsOliver ZivanovicDonal BrennanCedric NadeauWillemien Van DrielNaoual BakrinPompiliu PisoVictor J VerwaalSantiago González-MorenoMohammad AlyamiOlivia SgarburaBeate RauMarcello DeracoOlivier GlehenPublished in: Journal of surgical oncology (2024)
The 2022 PSOGI (Peritoneal Surface Oncology Group International) and RENAPE (French Network for Rare Peritoneal Malignancies) consensus on hyperthermic intraperitoneal chemotherapy (HIPEC) was a comprehensive effort aimed at standardizing treatment protocols for various peritoneal malignancies. This initiative is critical due to the wide range of technical variations in HIPEC procedures and the resulting need for standardization to ensure consistent and effective patient care and meaningful audit of multicenter data.